Study Quantifies Global T2DM, CVD Burdens Attributable to Sugary Drinks

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 9, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Jan. 8, 2025 -- Overall, 9.8 percent of all incident type 2 diabetes (T2D) cases and 3.1 percent of incident cardiovascular disease (CVD) cases were attributable to sugar-sweetened beverages (SSBs) worldwide in 2020, according to a study published online Jan. 6 in Nature Medicine.

Laura Lara-Castor, Ph.D., from Tufts University in Boston, and colleagues incorporated data from the Global Dietary Database to estimate SSB-attributed T2D and CVD burdens across 184 countries in 1990 and 2020 globally, regionally, and nationally.

The researchers found that in 2020, 2.2 and 1.2 million new T2D cases and CVD cases, respectively, were attributable to SSBs worldwide, representing 9.8 and 3.1 percent of all incident cases, respectively. Proportional SSB-attributable burdens were higher globally among men than women, for younger than older adults, for higher- than lower-educated adults, and in urban versus rural areas. The highest SSB-attributable percentage burdens were in Latin America and the Caribbean (24.4 percent for T2D and 11.3 percent for CVD) and sub-Saharan Africa (21.5 and 10.5 percent for T2D and CVD, respectively) by world region. Sub-Saharan Africa had the largest proportional increases in SSB-attributable incident T2D and CVD from 1990 to 2020 (+8.8 and +4.4 percent, respectively).

"These findings emphasize the need for targeted interventions, accounting for social inequities and aligned with global health objectives," the authors write. "While some policies to curb SSB intakes are currently in place in some countries, our study suggests that more work is needed."

Several authors disclosed ties to the pharmaceutical and health technology industries.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-09 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords